Rx Marketplace Quarterly: Q3 2017 Pharmaceutical and Life Sciences

The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry. In each issue we also discuss the most recent quarters' industry IPO's, venture capital funding and M&A activity. 

"The third quarter of 2017 is showing positive signs related to deal pricing as four of the seven completed deals to date have upsized compared to initial expectations."

Laura Robinette, US pharmaceuticals and life sciences assurance leader

Included in this edition of Rx Marketplace Quarterly:

  • We highlight the latest tax reform proposals, including the recent statement by the “Big Six” working group. 
  • We provide updates from the SEC on the new revenue recognition standard.
  • We also discuss recent updates from the SEC as part of their ongoing efforts to facilitate capital formation. 
  • A spotlight section focuses on cybersecurity and the expanding risks facing PLS companies.

Contact us

Laura Robinette
US Pharmaceutical and life sciences Assurance Leader
Tel: +1 (919) 791 4100

Follow us